SearchDictionaryMobileLogin

Renal Hypertension

1033  relevant articles (24 outcomes, 83 trials/studies) found for this Disease

Description: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.

Also Known As:
Hypertension, Renal; Hypertensions, Renal; Renal Hypertensions

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hypertension (High Blood Pressure)
2. Cardiomegaly (Heart Hypertrophy)
3. Renal Artery Obstruction (Renal Artery Stenosis)
4. Pheochromocytoma
5. Heart Failure

Experts

1. Prewitt, R L: 2 articles (09/2001 - 02/2000)
2. Dobrian, A D: 2 articles (09/2001 - 02/2000)
3. Heinig, Marcelo: 1 article (12/2006)
4. Johnson, Richard J: 1 article (12/2006)
5. Lobo, Peter I: 1 article (02/2006)
6. Burtner, Christopher: 1 article (02/2006)
7. Okusa, Mark D: 1 article (02/2006)
8. Hu, Daniel C: 1 article (02/2006)
9. Hong, Anna: 1 article (02/2006)
10. Rizkalla, Bishoy: 1 article (04/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Renal Hypertension:
1. EnalaprilFDA LinkGeneric
2. Captopril (Capoten)FDA LinkGeneric
3. ReninIBA
4. SodiumIBA
5. Angiotensin IIIBA
6. Hydralazine (Apresoline)FDA LinkGeneric
7. Labetalol (Normodyne)FDA LinkGeneric
8. Ramipril (Altace)FDA LinkGeneric
9. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10. Reserpine (Serpasil)FDA Link
05/01/1966 - "[The hypotensive effect of reserpine, furosemide and reserpine in combination with furosemide in experimental renal hypertension in rats]"
05/01/1958 - "Sodium restriction and reserpine administration in experimental renal hypertension; a correlation of arterial blood pressure responses with the ionic composition of the arterial wall."
09/01/1976 - "Tests conducted on anesthetized rats with experimental renal hypertension demonstrated that octadine, reserpine and methyl-DOPA with their one-time administration produce at the onset of the maximal hypotensine effect of fall of the arterial pressure at the expense of the lowered total peripheral resistance. "
01/01/1997 - "TRX was also as effective in decreasing urinary albumin excretion and preserving the renal function as ACEI or AIIRA in Group I. The improvement of albuminuria, glomerular enlargement and sclerosis after these treatments in Group II was significantly less than that in Group I. It appears that the early treatment with angiotensin converting enzyme inhibitor, angiotensin II receptor antagonist or reserpine, hydralazine and hydrochlorothiazide (TRX) may prevent glomerular injury in human patients with renal hypertension."
01/01/1984 - "Fifty-five patients suffering from essential or renal hypertension who had been insufficiently treated previously with combination therapy using diuretics and beta-blockers as well as reserpine, clonidine, prazosin, captopril, or minoxidil have been included in this open study. "
Order ALL the reference details at left...

Therapies and Procedures

1. Nephrectomy
2. Surgical Instruments (Clip)
3. Ligation
4. Transplantation (Transplant Recipients)
5. Angioplasty (Angioplasties)

Best Treatments:
Research Summary Report
on Renal Hypertension
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 24 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>